ClinicalTrials.gg
RecruitingNCT07594782Updated Aug 21, 2026

ED Medicaid Support

An interventional study of Navigation through financial systems and linkage to resources in Pediatric Uninsured Emergency Visits and Emergencies, sponsored by Hackensack Meridian Health. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-21.

Primary conditionnone(registry's first term: Emergencies)No conditionIs this wrong?Emergencies describes something many studies share rather than a condition a study is about. The study names no condition we can place it under, so it is not compared with other studies by condition.

Sponsored by Hackensack Meridian Health · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The study introduces a bedside intervention assisting families with the enrollment or re-enrollment process through patient direct contact with NJFamily Care and financial departments, using an emergency department (ED)-based navigator tool. The primary objective is to identify the barriers contributing to the lack of insurance coverage through NJ Family Care coverage using a brief survey with the parents of children who are treated in the ED and identified as uninsured, and to study the effect of a bedside intervention designed to assist families with the enrollment or re-enrollment process.

02

Conditions studied

  • Pediatric Uninsured Emergency Visits
  • Emergencies

Browse trials for

Keywords

  • Pediatric uninsured emergency visits
  • lack of insurance
  • linkage to resources
  • Medicaid
03

In context

Lead sponsor

Hackensack Meridian Health is the lead sponsor of 113 studies on the registry; 28 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 12 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parent/guardian/ legal authorized representative (age 18 years or older) with children aged: 1 month to 17 years of age who obtain care in the pediatric emergency department
  • Child Uninsured (ie, Charity Care, HUMC Charity Care, Pending Medicaid, Self-Pay)
  • Interested in applying or receiving assistance with NJfamilycare
  • Not pending private insurance coverage
  • Primary language of the parent or guardian is identified as English
  • Pediatric patient lives in New Jersey

Exclusion criteria

Exclusion Criteria:

  • Parent/guardian/legal authorized representative with children aged: less than 1 month and greater than 17 years old Insured pediatric patient Parent/ Guardian/Legal Authorized Representative not present Parent/ Guardian/Legal Authorized Representative age 17 years or younger Primary language not identified as English Patients visiting the Emergency Department related to Motor Vehicle Accidents Already participated in this study
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Bedside intervention and support

    A bedside intervention assisting families with the enrollment or re-enrollment process through patient direct contact with NJFamily Care and local financial departments, using an ED-based navigator tool.

    Other: Navigation through financial systems and linkage to resources

Interventions

  • OtherNavigation through financial systems and linkage to resources

    Navigation through financial systems and linkage to resources to connect families and ultimately help them gain access to insurance for the pediatric patient.

06

What researchers measure

Primary outcomes

  1. Barriers to medicaid enrollment or reenrollment

    Outcome of questionnaire regarding barriers expressed as percentage of participants who identified each barrier

    Time frame: Survey is completed upon enrollment

  2. Rate of Successful Medicaid Enrollment or Re-enrollment Approval

    The proportion of the enrolled participants who reported approval for Medicaid coverage. This outcome measures the ultimate success of the intervention of re-establishing health insurance.

    Time frame: Assessed via participant follow-up call or review of the electronic health record at 90 days post-intervention.

Secondary outcomes

  1. Enrollment in Temporary Insurance Coverage

    The proportion of participants who, after receiving additional assistance, were successfully enrolled in a temporary or bridge insurance plan, known as presumptive eligibility. This measures the intervention's success in providing a safety net for families during the Medicaid application waiting period.

    Time frame: Assessed via participant follow-up within 10 days (+/- 5 days) post-intervention and/or chart review.

07

Study locations

1 of 1 sites recruiting
  • Hackensack Univarsity medical Center
    Hackensack, New Jersey 07601, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2026 (actual). Primary completion is estimated for Aug 2028, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 11, 2026
First posted
May 19, 2026
StartActual
Aug 19, 2026
Primary completionEst.
Aug 13, 2028
CompletionEst.
Aug 13, 2028
Last update
Aug 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07594782
Collaborators
New Jersey Health Foundation
Responsible party
Sponsor
First posted
May 19, 2026
Start date
Aug 19, 2026
Primary completion
Aug 13, 2028 (estimated)
Completion
Aug 13, 2028 (estimated)
Last update
Aug 21, 2026

Study contacts

Daisy Negron, MBA, BSN, RN
Contact
Daisy.Negron@hmhn.org
551-996-3206
Karen Eigen, MD, MPH
principal investigator · Hackensack Meridian Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion